Table 1.
Patient baseline characteristics
| Characteristics | No of patients (%/range) | |
|---|---|---|
|
| ||
| Gender | Male | 41 (47.1%) |
| Female | 46 (52.9%) | |
| Age (years)a | Median (range) | 68 (38–80) |
| ≥70 | 34 (39.1%) | |
| <70 | 53 (60.9%) | |
| BMI (kg/m2) | Median (range) | 22.6 (16.5–29.3) |
| <18.5 | 34 (39.1%) | |
| 18.5–24 | 39 (44.8%) | |
| >24 | 14 (16.1%) | |
| KPSa | Median (range) | 80 (60–100) |
| ≥80 | 58 (66.7%) | |
| <80 | 29 (33.3%) | |
| VASa | Median (range) | 3 (0–8) |
| ≥4 | 61 (70.1%) | |
| <4 | 26 (29.9%) | |
| Tumor location | Head | 52 (59.8%) |
| Body | 29 (33.3%) | |
| Tail | 6 (6.9%) | |
| Prior treatment | Chemotherapy | 26 (29.9%) |
| Radiotherapy | 6 (6.9%) | |
| Surgery | 12 (13.8%) | |
| None | 31 (35.6%) | |
| Tumor size (cm) | Median (range) | 3.7 (1.7–6.9) |
| ≥3 | 41 (47.1%) | |
| <3 | 46 (52.9%) | |
| CA 19-9 (U/mL) | Median (range) | 3,779 (0–23,790) |
| Positive | 77 (88.5%) | |
| Negative | 10 (11.5%) | |
Notes:
a
Data are median (range); n (%).
Abbreviations: BMI, body mass index; CA, carbohydrate antigen; KPS, Karnofsky performance status.